Human hematopoietic stem/progenitor cells display reactive oxygen species-dependent long-term hematopoietic defects after exposure to low doses of ionizing radiations.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
08 2020
Historique:
received: 14 05 2019
accepted: 27 11 2019
pubmed: 30 11 2019
medline: 28 4 2021
entrez: 30 11 2019
Statut: ppublish

Résumé

Hematopoietic stem cells are responsible for life-long blood cell production and are highly sensitive to exogenous stresses. The effects of low doses of ionizing radiations on radiosensitive tissues such as the hematopoietic tissue are still unknown despite their increasing use in medical imaging. Here, we study the consequences of low doses of ionizing radiations on differentiation and self-renewal capacities of human primary hematopoietic stem/progenitor cells (HSPC). We found that a single 20 mGy dose impairs the hematopoietic reconstitution potential of human HSPC but not their differentiation properties. In contrast to high irradiation doses, low doses of irradiation do not induce DNA double strand breaks in HSPC but, similar to high doses, induce a rapid and transient increase of reactive oxygen species (ROS) that promotes activation of the p38MAPK pathway. HSPC treatment with ROS scavengers or p38MAPK inhibitor prior exposure to 20 mGy irradiation abolishes the 20 mGy-induced defects indicating that ROS and p38MAPK pathways are transducers of low doses of radiation effects. Taken together, these results show that a 20 mGy dose of ionizing radiation reduces the reconstitution potential of HSPC suggesting an effect on the self-renewal potential of human hematopoietic stem cells and pinpointing ROS or the p38MAPK as therapeutic targets. Inhibition of ROS or the p38MAPK pathway protects human primary HSPC from low-dose irradiation toxicity.

Identifiants

pubmed: 31780635
pii: haematol.2019.226936
doi: 10.3324/haematol.2019.226936
pmc: PMC7395291
doi:

Substances chimiques

Reactive Oxygen Species 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2044-2055

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright© 2020 Ferrata Storti Foundation.

Références

Cell Rep. 2019 Nov 19;29(8):2307-2320.e6
pubmed: 31747603
Blood. 2007 Oct 15;110(8):3056-63
pubmed: 17595331
Blood. 1996 Nov 1;88(9):3306-13
pubmed: 8896394
Cell Stem Cell. 2011 Sep 2;9(3):262-71
pubmed: 21885021
Ann Hematol. 2012 Jun;91(6):813-23
pubmed: 22258328
Nature. 2004 Oct 21;431(7011):997-1002
pubmed: 15496926
J Med Imaging Radiat Oncol. 2011 Apr;55(2):107-9
pubmed: 21501396
Cell Stem Cell. 2010 Aug 6;7(2):186-97
pubmed: 20619763
Nature. 2007 Jun 7;447(7145):686-90
pubmed: 17554302
Nat Rev Genet. 2000 Oct;1(1):57-64
pubmed: 11262875
Radiat Res. 2011 Dec;176(6):743-52
pubmed: 22014293
Nat Med. 2014 Aug;20(8):833-46
pubmed: 25100529
J Exp Med. 2015 Apr 6;212(4):525-38
pubmed: 25824820
Leukemia. 2015 Jul;29(7):1543-54
pubmed: 25652738
Blood. 2008 Mar 1;111(5):2621-30
pubmed: 18156489
Cell Stem Cell. 2013 Jan 3;12(1):37-48
pubmed: 23246483
Science. 2011 Jul 8;333(6039):218-21
pubmed: 21737740
Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1470-4
pubmed: 8643656
Pharmacol Res. 2018 Oct;136:45-55
pubmed: 30142422
Blood. 2011 Oct 27;118(17):4609-19
pubmed: 21868569
Cell Mol Immunol. 2012 May;9(3):208-14
pubmed: 22327211
Cell Stem Cell. 2019 Sep 5;25(3):329-341.e6
pubmed: 31327664
Trends Mol Med. 2016 Aug;22(8):701-712
pubmed: 27380967
Blood. 2001 Oct 1;98(7):2043-51
pubmed: 11567988
Stem Cells. 2016 Jun;34(6):1651-63
pubmed: 26930546
Nature. 2007 Jun 7;447(7145):725-9
pubmed: 17554309
Blood. 2012 Jun 28;119(26):6255-8
pubmed: 22555972
Curr Top Dev Biol. 2016;118:21-44
pubmed: 27137653
Nat Med. 2000 Nov;6(11):1235-40
pubmed: 11062534
Leukemia. 2016 Oct;30(10):1968-1978
pubmed: 27443261
Stem Cells. 2015 Jul;33(7):2268-79
pubmed: 25858676
Nat Med. 2006 Apr;12(4):446-51
pubmed: 16565722
Cell Stem Cell. 2011 Sep 2;9(3):247-61
pubmed: 21885020
Nat Med. 2014 Dec;20(12):1472-8
pubmed: 25326804
Blood. 2011 Sep 15;118(11):2941-50
pubmed: 21734240
Lancet. 2012 Aug 4;380(9840):499-505
pubmed: 22681860
Aging Cell. 2015 Apr;14(2):153-61
pubmed: 25645467
Cell Rep. 2017 Sep 26;20(13):3199-3211
pubmed: 28954235
Exp Hematol. 1999 Sep;27(9):1418-27
pubmed: 10480433
Cell Stem Cell. 2012 Feb 3;10(2):120-36
pubmed: 22305562
PLoS One. 2011 Mar 07;6(3):e17487
pubmed: 21408175
Cell Stem Cell. 2007 Dec 13;1(6):635-45
pubmed: 18371405
Development. 2014 Dec;141(24):4656-66
pubmed: 25468935
Cell Death Differ. 2018 May;25(5):983-1001
pubmed: 29323266
Nature. 2015 Apr 23;520(7548):549-52
pubmed: 25707806
Free Radic Res. 2005 Feb;39(2):153-62
pubmed: 15763963
PLoS One. 2012;7(3):e33499
pubmed: 22448248
Blood. 2006 Nov 1;108(9):2998-3004
pubmed: 16849639

Auteurs

Elia Henry (E)

INSERM, U1274, Laboratory "Niche, Cancer and Hematopoiesis".
CEA, DRF-JACOB-IRCM-SCSR-LSHL, UMR "Genetic stability, Stem Cells and Radiation".
UMR "Genetic stability, Stem Cells and Radiation" Université de Paris.
UMR "Genetic stability, Stem Cells and Radiation", Université Paris-Saclay.

Inès Souissi-Sahraoui (I)

INSERM, U1274, Laboratory "Niche, Cancer and Hematopoiesis".
CEA, DRF-JACOB-IRCM-SCSR-LSHL, UMR "Genetic stability, Stem Cells and Radiation".
UMR "Genetic stability, Stem Cells and Radiation" Université de Paris.
UMR "Genetic stability, Stem Cells and Radiation", Université Paris-Saclay.

Margaux Deynoux (M)

INSERM, U1274, Laboratory "Niche, Cancer and Hematopoiesis".
CEA, DRF-JACOB-IRCM-SCSR-LSHL, UMR "Genetic stability, Stem Cells and Radiation".
UMR "Genetic stability, Stem Cells and Radiation" Université de Paris.
UMR "Genetic stability, Stem Cells and Radiation", Université Paris-Saclay.

Andréas Lefèvre (A)

INSERM, U1274, Laboratory "Niche, Cancer and Hematopoiesis".
CEA, DRF-JACOB-IRCM-SCSR-LSHL, UMR "Genetic stability, Stem Cells and Radiation".
UMR "Genetic stability, Stem Cells and Radiation" Université de Paris.
UMR "Genetic stability, Stem Cells and Radiation", Université Paris-Saclay.

Vilma Barroca (V)

INSERM, U1274, Laboratory "Niche, Cancer and Hematopoiesis".
CEA, DRF-JACOB-IRCM-SCSR-LSHL, UMR "Genetic stability, Stem Cells and Radiation".
UMR "Genetic stability, Stem Cells and Radiation" Université de Paris.
UMR "Genetic stability, Stem Cells and Radiation", Université Paris-Saclay.

Anna Campalans (A)

UMR "Genetic stability, Stem Cells and Radiation" Université de Paris.
UMR "Genetic stability, Stem Cells and Radiation", Université Paris-Saclay.
CEA, DRF-JACOB-IRCM-SIGRR-LRIG, UMR "Genetic stability, Stem Cells and Radiation".

Véronique Ménard (V)

UMR "Genetic stability, Stem Cells and Radiation" Université de Paris.
UMR "Genetic stability, Stem Cells and Radiation", Université Paris-Saclay.
UMR "Genetic stability, Stem Cells and Radiation", F-92265 Fontenay-aux-Roses, France.

Julien Calvo (J)

INSERM, U1274, Laboratory "Niche, Cancer and Hematopoiesis".
CEA, DRF-JACOB-IRCM-SCSR-LSHL, UMR "Genetic stability, Stem Cells and Radiation".
UMR "Genetic stability, Stem Cells and Radiation" Université de Paris.
UMR "Genetic stability, Stem Cells and Radiation", Université Paris-Saclay.

Françoise Pflumio (F)

INSERM, U1274, Laboratory "Niche, Cancer and Hematopoiesis".
CEA, DRF-JACOB-IRCM-SCSR-LSHL, UMR "Genetic stability, Stem Cells and Radiation".
UMR "Genetic stability, Stem Cells and Radiation" Université de Paris.
UMR "Genetic stability, Stem Cells and Radiation", Université Paris-Saclay.

Marie-Laure Arcangeli (ML)

INSERM, U1274, Laboratory "Niche, Cancer and Hematopoiesis" marie-laure.arcangeli@inserm.fr.
CEA, DRF-JACOB-IRCM-SCSR-LSHL, UMR "Genetic stability, Stem Cells and Radiation".
UMR "Genetic stability, Stem Cells and Radiation" Université de Paris.
UMR "Genetic stability, Stem Cells and Radiation", Université Paris-Saclay.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH